World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
89
Citations
29845
World Ranking
12667
National Ranking
393

Norbert Ifrah publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Norbert Ifrah sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 472 publications — 53rd percentile

53% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Norbert Ifrah D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Norbert Ifrah sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 89 D-Index — 38th percentile

38% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Norbert Ifrah is affiliated with Grenoble Alpes University in France. The research primarily focuses on medical sciences, with a substantial body of work in hematology, public health, immunology, genetics, and oncology.

Their research topics cover various aspects of leukemia and cancer treatment, including:

  • Acute Lymphoblastic Leukemia research
  • Chronic Myeloid Leukemia Treatments
  • Acute Myeloid Leukemia Research
  • Lymphoma Diagnosis and Treatment
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Childhood Cancer Survivors' Quality of Life
  • Immune Cell Function and Interaction

Norbert Ifrah has contributed to numerous papers, among which several recent publications include:

  • Lactic Acidosis Together with GM-CSF and M-CSF Induces Human Macrophages toward an Inflammatory Protumor Phenotype, 2020, Cancer Immunology Research
  • Leukemic evolution of polycythemia vera and essential thrombocythemia: genomic profiles predict time to transformation, 2020, Blood Advances
  • Epigenetic analysis of patients with T-ALL identifies poor outcomes and a hypomethylating agent-responsive subgroup, 2021, Science Translational Medicine
  • Clinico-biological features of T-cell acute lymphoblastic leukemia with fusion proteins, 2022, Blood Cancer Journal
  • NGS-based stratification refines the risk stratification in T-ALL and identifies a very-high-risk subgroup of patients, 2024, Blood

The frequent co-authors in their work include:

  • Hervé Dombret
  • Nicolas Boissel
  • Mathilde Hunault
  • Vahid Asnafi
  • Françoise Huguet

Norbert Ifrah's research appears predominantly in specialized medical and hematology journals. The most frequent publication venues include:

  • Blood
  • Global Health Promotion
  • Leukemia
  • European Journal Of Haematology
  • Blood Advances

Best Publications

  • A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome.

    Michel Attal;Jean-Luc Harousseau;Anne-Marie Stoppa;Jean-Jacques Sotto

  • Addition of gemtuzumab ozogamicin to induction chemotherapy in adult patients with acute myeloid leukaemia: A meta-analysis of individual patient data from randomised controlled trials

    Robert Kerrin Hills;Sylvie Castaigne;Frederick R. Appelbaum;Jacques Delaunay

  • Interferon alfa-2b combined with cytarabine versus interferon alone in chronic myelogenous leukemia

    Guilhot F;Chastang C;Michallet M;Guerci A

  • Pediatric-Inspired Therapy in Adults With Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia: The GRAALL-2003 Study

    Françoise Huguet;Thibaut Leguay;Emmanuel Raffoux;Xavier Thomas

  • Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells.

    Dorothée Duluc;Dorothée Duluc;Yves Delneste;Yves Delneste;Fang Tan;Fang Tan;Marie-Pierre Moles

  • Prevention of Oxaliplatin-Related Neurotoxicity by Calcium and Magnesium Infusions: A Retrospective Study of 161 Patients Receiving Oxaliplatin Combined with 5-Fluorouracil and Leucovorin for Advanced Colorectal Cancer

    Laurence Gamelin;Michele Boisdron-Celle;Remy Delva;Véronique Guérin-Meyer

  • Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia - Results of the GRAAPH-2003 study

    Adrienne de Labarthe;Philippe Rousselot;Francoise Huguet-Rigal;Eric Delabesse

  • Impact of T-cell depletion on outcome of allogeneic bone-marrow transplantation for standard-risk leukaemias.

    D. Maraninchi;D. Blaise;B. Rio;V. Leblond

  • Randomized study of reduced-intensity chemotherapy combined with imatinib in adults with Ph-positive acute lymphoblastic leukemia

    Yves Chalandon;Xavier Thomas;Sandrine Hayette;Jean-Michel Cayuela

  • Prospective evaluation of gene mutations and minimal residual disease in patients with core binding factor acute myeloid leukemia

    Eric Jourdan;Nicolas Boissel;Sylvie Chevret;Eric Delabesse

  • Allogeneic Marrow Stem-Cell Transplantation From Human Leukocyte Antigen–Identical Siblings Versus Human Leukocyte Antigen–Allelic–Matched Unrelated Donors (10/10) in Patients With Standard-Risk Hematologic Malignancy: A Prospective Study From the French Society of Bone Marrow Transplantation and Cell Therapy

    Ibrahim Yakoub-Agha;Florence Mesnil;Mathieu Kuentz;Jean Michel Boiron

  • Mammalian target of rapamycin (mTOR) inhibition activates phosphatidylinositol 3-kinase/Akt by up-regulating insulin-like growth factor-1 receptor signaling in acute myeloid leukemia: rationale for therapeutic inhibition of both pathways

    Jerome Tamburini;Nicolas Chapuis;Valérie Bardet;Sophie Park

  • Rituximab in B-Lineage Adult Acute Lymphoblastic Leukemia.

    Sébastien Maury;Sylvie Chevret;Xavier Thomas;Dominik Heim

  • Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission: a randomized trial of a busulfan-Cytoxan versus Cytoxan-total body irradiation as preparative regimen: a report from the Group d'Etudes de la Greffe de Moelle Osseuse.

    D Blaise;D Maraninchi;E Archimbaud;J Reiffers

  • Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia.

    Kheira Beldjord;Sylvie Chevret;Vahid Asnafi;Françoise Huguet

  • Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans retinoic acid and chemotherapy: the European APL Group experience

    Lionel Adès;Lionel Adès;Agnes Guerci;Emmanuel Raffoux;Miguel Sanz

  • Essential role for the p110δ isoform in phosphoinositide 3-kinase activation and cell proliferation in acute myeloid leukemia

    Pierre Sujobert;Valerie Bardet;Pascale Cornillet-Lefebvre;Joel S. Hayflick

  • Better outcome of adult acute lymphoblastic leukemia after early genoidentical allogeneic bone marrow transplantation (BMT) than after late high-dose therapy and autologous BMT: a GOELAMS trial

    Mathilde Hunault;Jean-Luc Harousseau;Martine Delain;Malgorzata Truchan-Graczyk

  • Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemia.

    Lise Willems;Lise Willems;Nathalie Jacque;Arnaud Jacquel;Nathalie Neveux

  • NOTCH1/FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): a Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) study.

    Vahid Asnafi;Vahid Asnafi;Agnès Buzyn;Sandrine Le Noir;Sandrine Le Noir;Frédéric Baleydier;Frédéric Baleydier

Frequent Co-Authors

Hervé Dombret
Hervé Dombret Université Paris Cité
Christian Recher
Christian Recher Federal University of Toulouse Midi-Pyrénées
Elizabeth Macintyre
Elizabeth Macintyre Necker-Enfants Malades Hospital
Jean-Luc Harousseau
Jean-Luc Harousseau University of Nantes
Nicolas Boissel
Nicolas Boissel Université Paris Cité
Mauricette Michallet
Mauricette Michallet University of Helsinki
Eric Delabesse
Eric Delabesse Cancer Research Center of Toulouse
Claude Preudhomme
Claude Preudhomme University of Lille
Emmanuel Raffoux
Emmanuel Raffoux Hôpital Saint-Louis

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're exploring medical education options, there are several flexible online degrees and career pathways that can open doors in health and medicine. For those interested in nutrition, pursuing a bachelor's in nutrition online provides a strong foundation in health science, making it easier to work as a nutritionist or transition to clinical healthcare roles.

Healthcare leadership is also a popular option. Many professionals choose cahme accredited online healthcare administration programs to prepare for management careers in hospitals, clinics, and public health organizations. These programs accommodate working professionals with coursework designed for online completion.

For registered nurses who want to advance without on-site clinical requirements, online rn to bsn programs no clinicals offer an accelerated and flexible route to a bachelor’s degree. Nurses looking to move further may consider doctoral study; a 1 year dnp program online is one of the fastest ways to reach the highest level in nursing practice.

These alternative online pathways are ideal for students balancing work and study, or those seeking specialized expertise outside the traditional medical degree.

Best Scientists Citing Norbert Ifrah

Trending Scientists

Recently Published Articles